XML 27 R7.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (6,592,723) $ (3,028,448)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 6,811 5,972
Change in fair value of derivative liabilities (2,216,488) (94,025)
Amortization of debt discount and finance fees 2,123,049 885,505
Gain on marketable securities (4,970)
Change in fair value of marketable securities (71,568)
Accrued interest settled with common stock 294,927
Loss on settlement of convertible debt 477,221
Gain on settlement of accounts payable (328,687)
Gain on forgiveness of Paycheck Protection Program note payable (73,007)
Gain on interest relief on conversion of notes payable 12,625
Stock-based compensation 181,960 403,956
Changes in operating assets and liabilities:    
Accrued interest income (14,901)
Prepaid expenses 46,675 (156,282)
Accounts payable and accrued expenses 166,115 (382,881)
Accounts payable and accrued expenses - related parties (12,054) 12,500
Accrued interest payable 110,453 (13,177)
Accrued interest payable - related parties (98,135) 51,188
Other assets 6,480
Change in operating lease asset and liability 16,001 (5,693)
Net cash used in operating activities (5,581,147) (2,710,454)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Investment in marketable securities (2,998,572)
Proceeds from disposition of marketable securities 187,895
Purchase of equipment (19,046)
Net cash used in investing activities (2,829,723)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common shares and exercise of warrants 10,022,193
Proceeds from note payable-related party 50,000
Repayment of note payable-related party (685,473) (50,000)
Proceeds from convertible notes payable and warrants 3,935,000 600,715
Payment for finance costs related to convertible note payable (345,000)
Payment of convertible note payable (334,444)
Net cash provided by financing activities 2,570,083 10,622,908
Net change in cash and cash equivalents (5,840,787) 7,912,454
Cash and cash equivalents, beginning of period 8,417,203 504,749
Cash and cash equivalents, end of period 2,576,416 8,417,203
Cash paid for:    
Interest 164,807 39,201
Supplemental non-cash financing activities:
Common stock issued for conversion of accrued interest 16,340
Common stock issued for settlement of debt 2,697,849 588,524
Common stock issued for exercise of warrants with settlement of notes payable 576,476
Common stock issued for dividend payable 402,068
Warrants issued for financing fees, net of issuance fees of $8,727 and $0, respectively 90,816 412,241
Initial recognition of right of use asset and liability $ 365,556